Puma Biotechnology Senior Vice President, Regulatory Affairs, Medical Writing and Project Management Douglas Hons receives $6.8M in 2018
Puma Biotechnology reports 2018 executive compensation
By ExecPay News
Published: April 29, 2019
Puma Biotechnology reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, six executives at Puma Biotechnology received on average a compensation package of $3.5M, a 66% increase compared to previous year.
Average pay of disclosed executives at Puma Biotechnology
Douglas Hunt, B. Sc Hons, Senior Vice President, Regulatory Affairs, Medical Writing and Project Management, received $6.8M in total. 93% of Hons' compensation, or $6.3M, was in option awards. Hons also received $149K in bonus, $330K in salary, as well as $2.8K in other compensation.
Alan H. Auerbach, Chief Executive Officer, received a compensation package of $6.2M, which increased by 121% compared to previous year. 43% of the compensation package, or $2.7M, was in option awards.
Maximo F. Nougues, Chief Financial Officer, earned $2.3M in 2018.
Steven Lo, Chief Commercial Officer, received $2.2M in 2018, which increases by 59% compared to 2017.
Richard P. Bryce, B, MRCGP and MFPM Senior Vice President, Clinical Research and Development, earned $1.9M in 2018, a 40% increase compared to previous year.
Charles R. Eyler, Senior Vice President, Finance and Administration, received $1.8M in 2018, which decreases by 37% compared to 2017.
Related executives
Alan Auerbach
Puma Biotechnology
Chief Executive Officer
Charles Eyler
Puma Biotechnology
Senior Vice President, Finance and Administration
Maximo Nougues
Puma Biotechnology
Chief Financial Officer
Richard Bryce
Puma Biotechnology
B, MRCGP and MFPM Former Chief Medical and Scientific Officer
Steven Lo
Puma Biotechnology
Chief Commercial Officer
Douglas Hons
Puma Biotechnology
Senior Vice President, Regulatory Affairs, Medical Writing and Project Management
You may also like
Source: SEC filing on April 29, 2019.